tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC

Elicera Therapeutics AB (ELIC) Revenue

Compare
1 Followers

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had a revenue of 0.00 in the quarter ending Dec 31, 2024, with -100.00%. This bring the company's revenue in the last twelve months to 4.26M, Increased -0.65%. In the fiscal year ending Dec 31, 2024, Elicera Therapeutics AB had annual revenue of 7.13M with -36.53% growth.
Revenue (ttm)
4.26M
Revenue Growth
P/S Ratio
35.20
Revenue/Employee
kr3,564,000
Employees
2
Market Cap
kr250.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.13M-4.10M-36.53%
Dec 31, 2023
11.23M9.95M+777.34%
Dec 31, 2022
1.28M1.28M+217,957.92%
Dec 31, 2021
587.00+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis